CHRO — ChromoGenics AB Share Price
0.000.00%
Last trade - 00:00- SEK32.34m
- SEK91.23m
- SEK13.65m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.76 | ||
| Price to Tang. Book | 1.01 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 2.37 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -43.6% | ||
| Return on Equity | -92.73% | ||
| Operating Margin | -357.24% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | 45.25 | 14.62 | 24.69 | 18.26 | 13.64 | 29 | 45 | 3.95% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
ChromoGenics AB is a Sweden-based company, which develops, manufactures and markets foil-based products with controllable optical properties and conducts related business. The Company’s primary product is ConverLight, which is an electrochromic glass with dynamic solar control properties. This glass enables control of light influx to tone down the light and energy admission in various parts of property or premises. The glass is suitable for new construction, reconstruction and renovation and offers ultraviolet protection that reduces risk of fading interiors. The Company distributes ConverLight to commercial installation companies in Sweden and Norway. The main shareholders in the Company are K-Svets Venture AB and New Energy Solutions II K/S.
Directors
- Christer Simren CHM (60)
- Fredrik Franding CEO
- Lars Ericsson CFO
- Micael Hamberg COO (55)
- Asa Stroofe CMO
- Linus Wetterlind DSL
- Greger Gregard OTH (43)
- Victor Haegglund OTH
- Fredrik Rostvall OTH
- Anders Brannstrom DRC (73)
- Mari Broman DRC (69)
- Claes-Goran Granqvist DRC (71)
- Peter Gustafson DRC (59)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- July 5th, 2002
- Public Since
- March 23rd, 2017
- No. of Employees
- 33
- Sector
- Homebuilding & Construction Supplies
- Industry
- Consumer Cyclicals
- Exchange
- OMX Nordic Exchange Stockholm
- Shares in Issue
- 4,124,966
- Address
- Ullforsgatan 15, UPPSALA, 752 28
- Web
- https://chromogenics.com/
- Phone
- +46 184300430
- Auditors
- Grant Thornton Sweden AB
Upcoming Events for CHRO
ChromoGenics AB Annual Shareholders Meeting
Similar to CHRO
Assa Abloy AB
OMX Nordic Exchange Stockholm
Byggma ASA
OMX Nordic Exchange Stockholm
Fagerhult AB
OMX Nordic Exchange Stockholm
FlexQube AB (publ)
OMX Nordic Exchange Stockholm
FM Mattsson AB (publ)
OMX Nordic Exchange Stockholm
FAQ
What is the ChromoGenics AB share price?
As of Today at 19:05 UTC, shares in ChromoGenics AB are trading at SEK7.84. This share price information is delayed by 15 minutes.
How has the ChromoGenics AB share price performed this year?
Shares in ChromoGenics AB last closed at SEK7.84 and the price had moved by -48.68% over the past 365 days. In terms of relative price strength the ChromoGenics AB share price has underperformed the FTSE Global All Cap Index by -51.82% over the past year.
What are the analyst and broker recommendations for ChromoGenics AB?
There is no consensus recommendation for this security.
What is the ChromoGenics AB dividend yield?
ChromoGenics AB does not currently pay a dividend.
Does ChromoGenics AB pay a dividend?
ChromoGenics AB does not currently pay a dividend.
When does ChromoGenics AB next pay dividends?
ChromoGenics AB does not currently pay a dividend.
How do I buy ChromoGenics AB shares?
To buy shares in ChromoGenics AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of ChromoGenics AB?
As of the previous close price of SEK7.84, shares in ChromoGenics AB had a market capitalisation of SEK32.34m.
Where are ChromoGenics AB shares listed?
Here are the trading details for ChromoGenics AB:
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: CHRO
What kind of share is ChromoGenics AB?
Based on an overall assessment of its quality, value and momentum ChromoGenics AB is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a ChromoGenics AB share price forecast for 2024?
The analyst consensus target price for shares in ChromoGenics AB is SEK4.60. That is 41.33% below the last closing price of SEK7.84.
Analysts covering ChromoGenics AB currently have a consensus Earnings Per Share (EPS) forecast of -SEK4.00 for the next financial year.
What is the trend in the ChromoGenics AB share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like ChromoGenics AB. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +22.66%.
As of the last closing price of SEK7.84, shares in ChromoGenics AB were trading +11.65% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the ChromoGenics AB PE Ratio?
The ChromoGenics AB PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SEK7.84.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of ChromoGenics AB?
ChromoGenics AB's management team is headed by:
- Christer Simren - CHM
- Fredrik Franding - CEO
- Lars Ericsson - CFO
- Micael Hamberg - COO
- Asa Stroofe - CMO
- Linus Wetterlind - DSL
- Greger Gregard - OTH
- Victor Haegglund - OTH
- Fredrik Rostvall - OTH
- Anders Brannstrom - DRC
- Mari Broman - DRC
- Claes-Goran Granqvist - DRC
- Peter Gustafson - DRC